Methods and Data
Results and Discussion
Introduction
�
References
[1] Alvarez-Fischer, Daniel, et al. “Bee Venom and Its Component Apamin as Neuroprotective Agents in a Parkinson Disease Mouse Model.” PLoS ONE, vol. 8, no. 4, 2013, doi:10.1371/journal.pone.0061700.
[2] Haghi, Ghasem, et al. “Qualitative and Quantitative Evaluation of Melittin in Honeybee Venom and Drug Products Containing Honeybee Venom.” Journal of Apicultural Science, vol. 57, no. 2, 2013, pp. 37–44., doi:10.2478/jas-2013-0015.
[3] Jang, Soobin, and Kyeong Han Kim. “Clinical Effectiveness and Adverse Events of Bee Venom Therapy: A Systematic Review of Randomized Controlled Trials.” Toxins, vol. 12, no. 9, 2020, p. 558., doi:10.3390/toxins12090558.
[5] Kim, Yong-Wan, et al. “Honeybee Venom Possesses Anticancer and Antiviral Effects by Differential Inhibition of HPV E6 and E7 Expression on Cervical Cancer Cell Line.” Oncology Reports, vol. 33, no. 4, 2015, pp. 1675–1682., doi:10.3892/or.2015.3760.
[4] Marichal, Thomas, et al. “A Beneficial Role for Immunoglobulin E in Host Defense against Honeybee Venom.” Immunity, vol. 39, no. 5, 2013, pp. 963–975., doi:10.1016/j.immuni.2013.10.005.
[5] “My Experience with Bee Venom Therapy - by Rebecca Hayward.” Lyme Disease UK, 23 Mar. 2017, lymediseaseuk.com/2017/04/02/bee-venom-therapy-rebecca-hayward/.
[6] Palm, Noah W., et al. “Bee Venom Phospholipase A2 Induces a Primary Type 2 Response That Is Dependent on the Receptor ST2 and Confers Protective Immunity.” Immunity, vol. 39, no. 5, 2013, pp. 976–985., doi:10.1016/j.immuni.2013.10.006.
Conclusion
Interactions Between Bee Venom Therapy and the Human Body
Angelina Anderson